Indonesia allows Taiwan's COVID-19 vaccine candidate to conduct clinical trial
09/13/2021 12:05 PM
Taiwanese vaccine producer Adimmune Corp. said on Monday that it has gained approval from the Indonesian government to conduct Phase 2 clinical trials for its COVID-19 vaccine candidate, with results expected to be released next year.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Price of renewable energy should be left to market: Economic official
07/04/2024 10:50 PM - Cross-Strait
Taiwan asks China for information on seized fishing boat crew
07/04/2024 10:30 PM - Politics
Constitutional Court to hear arguments on oversight laws in August
07/04/2024 09:59 PM - Society
Cabinet passes plan to combat nursing shortage
07/04/2024 09:56 PM - Business
RE100 head calls on Taiwan to remove fossil fuel subsidies
07/04/2024 08:46 PM